Ironwood Pharmaceuticals

Ironwood Pharmaceuticals

IRWD· Manufacturing· Fiscal year ends in December

CEO pay in FY2025Stock -23.9% in FY2025

Thomas McCourt is the CEO of Ironwood Pharmaceuticals and was paid $1.9M in FY2025 (Dec), down 68%.

Pay$100 in the stock at the end of FY20 → $32
CEO pay is from each Ironwood Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives3

See all
  1. 1Thomas McCourtFY2025
  2. 2Tammi GaskinsFY2025
  3. 3Gregory MartiniFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Pay

See all

Ironwood Pharmaceuticals paid its 3 named executives $4.4M in total in FY2025 (Dec). CEO Thomas McCourt was paid $1.9M of that.

Name
Thomas McCourtChief Executive OfficerNot disclosed
Tammi GaskinsSenior Vice President, Chief Commercial OfficerNot disclosed
Gregory MartiniSenior Vice President, Chief Financial OfficerNot disclosed

of each named executive, from the Summary Compensation Table of each proxy.

Peers17

See all

The FY2024 (Dec) proxy of Ironwood Pharmaceuticals names 17 peer companies for pay. Pay versus performance data of Ironwood Pharmaceuticals for that year is not on file, so it has no rank.

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.

Board1

See all
  • Alexander DennerDirector · 5 yr on the boardIndependentGovernance and Nominating (Chair)—Paid as an executive

The board of the latest proxy (FY2025).

Activity

Filings6

See all
Proxy statementDEF 14AApr 28, 2026FY2025
Annual report10-KFeb 26, 2026FY2025
Proxy statementDEF 14AApr 28, 2025FY2024
Annual report10-KMar 31, 2025FY2024
Proxy statementDEF 14AApr 25, 2024FY2023
Annual report10-KFeb 16, 2024FY2023
For the press:Download CSVDownload PNGHow to use our data